Developments in molecular and genomics technologies are dramatically improving the opportunities for development of more effective cancer therapeutics. At Eurofins Viracor we offer a broad range of molecular and genomic services to support translational and precision medicine approaches to clinical development.
Polymerase chain reaction (PCR) technology is the gold standard in molecular testing.
With a wide range of viral and bacterial targets, our clients have access to a broad menu of real-time PCR and quantitative assays for pathogen detection and monitoring, biodistribution and shedding.
Our PCR technology expertise includes: qPCR, RT-PCR, TEM-PCR, ddPCR; and extends across a variety of applications and therapeutic areas.
Eurofins Viracor’s capabilities for supporting clinical studies with genomics testing includes: